Similar companies
| Company | Revenue | |
|---|---|---|
| No data for previous quarter available yet. | ||
Income Statement (USD)
| Q4 '24 | QoQ | |
|---|---|---|
| Revenue | 8.54B | 6.4% |
| Gross Profit | 2.38B | 11.4% |
| Cost of Revenue | 6.16B | 4.6% |
| Operating expense | 3.91B | 2.3% |
| Net Income | 1.27B | 21.9% |
| EBITDA | 2.01B | 18.7% |
Balance Sheet (USD)
| Q4 '24 | QoQ | |
|---|---|---|
| Total Assets | 90B | 0.3% |
| Total Liabilities | 41.3B | 0.6% |
| Total Equity | 48.5B | 1.1% |
| Shares Outstanding | 1.28B | 0% |
Cash Flow (USD)
| Q4 '24 | QoQ | |
|---|---|---|
| Cash from operations | 958M | 2.8% |
| Cash from investing | -345M | 33.2% |
| Cash from financing | -534M | 26.9% |
EPS
Financial Highlights for Medtronic in Q4 '24
Medtronic reported a revenue of 8.54B, which is a 6.4% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 2.38B, marking a 11.4% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 6.16B, a 4.6% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 3.91B, showing a 2.3% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 1.27B, showing a 21.9% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 2.01B, showing a 18.7% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for Medtronic with growth in revenue, gross profit, and net income. Higher operating expenses might indicate increased investments or potential inefficiencies.
